pooled plasma

pooled plasma

Etymology: AS, pol + Gk, plasma, something formed
plasma pooled from many donors and used to prepare plasma protein derivatives. Source plasma is plasma collected specifically for the manufacture of derivatives; recovered plasma is plasma separated from whole blood donations.
References in periodicals archive ?
PBM uses pooled plasma to create products which accelerate the healing of both bone and soft tissues.
In plasmapheresis, the whole blood of patient is withdrawn, plasma separated from the cellular constituents is discarded and the cellular constituents are reinfused back into the patient, together with albumin or pooled plasma.
The PBM technology was developed at Carnegie Mellon University and utilises pooled plasma to create products which accelerate the healing of both bone and soft tissues.
Reproducibility was determined by analysis of 232 aliquots of pooled plasma samples from individuals with CRC or from healthy blood donors.
illustrated that on column immuno-precipitation using an anti-sialyl lewis x IgM antibody in line with reversed phase chromatography had the ability to differentiate between a stage-2 ductal carcinoma plasma and NIST normal pooled plasma.
Negative selection was performed as the third step with pooled plasma from HIV-negative subjects.
Standard curves for plasma analysis were prepared by fortifying untreated, pooled plasma from Hispaniolan Amazon parrots with terbinafine to produce a linear concentration range of 5-1500 ng/mL.
What about immunogenicity and risk of infectious disease transmission of pooled plasma from 1,000 donors?
Incomplete choice of combination of tests on blood donation that should be used in each center, with absence of HCV NAT on pooled plasma, ELISA anti-CMV Ab, ELISA anti-HTLV-1 Ab, and optional test for malaria.
Eleven years earlier, the man had been treated with Factor VIII that was derived from pooled plasma in the United Kingdom, which included at least one donation from a person who had died of confirmed or probable vCJD.
In 2004, all patients with bleeding disorders including haemophilia treated with UK-sourced pooled plasma products between 1980 and 2001 were classed as "at risk" of vCJD due to the possibility of infection.
The triglyceride, HDL, LDL and total cholesterol of the plasma was determined and the atherogenic index (AI) of pooled plasma from each group of rats was calculated (AI = (total cholesterol-HDL cholesterol)/HDL cholesterol).